临床试验用品市场规模Bi价值3.40美元乐鱼体育手机网站入口llion By 2030

April 2022 | Report Format: Electronic (PDF)

Clinical Trial Supplies Market Growth & Trends

The globalclinical trial supplies marketsize is expected to reach USD 3.40 billion by 2030, registering a CAGR of 6.4% during the forecast period, according to a new report by Grand View Research, Inc. This growth can be attributed to the increasing volume of clinical trial studies coupled with the growing complexity of conducting these trials. The COVID-19 pandemic has created opportunities for local manufacturers. To enhance their foothold in the market, key companies are adopting various plans and policies to gain a higher market share. Theclinical trialand pharmaceutical industry is anticipated to witness steady growth, which, in turn, will increase the demand for clinical trial supplies, thereby driving the market growth.

Canada and the U.S. are home to the majority of clinical trials. No language barrier is one of the major factors for the preference of this region for the majority of clinical trials, as the English language is widely spoken in this region. Major CROs and biopharmaceutical companies have their hub in this region, and with advancements in technology, the demand for efficient supplies is increasing and the region is expected to dominate the clinical trial supplies market over the forecast period.

The outbreak of COVID-19 has presented one major challenge, that is, the supply chain vertical of every company is facing limited movement across borders, with national export bans. Thus, companies are adopting various strategies to supply their products to the required destination. The shift toward Direct-to-Patient (DTP) deliveries may overcome the crisis to some extent. The FDA & EMA and regulatory bodies of China, Singapore, & Korea are focusing on DTP deliveries, as an alternative distribution method for investigational product supplies. DTP deliveries have ensured patient adherence and increased participation in clinical trials. For instance, in April 2020, Marken witnessed an increase in onboarded DTP trials in comparison with previous weeks.

---

Request a free sample copy or view the report summary:Clinical Trial Supplies Market Report

---

Clinical Trial Supplies Market Report Highlights

• Based on the clinical phase, the market was dominated by the phase III segment in 2021 with a revenue share of over 52.0%, owing to the presence of a large number of molecules being under phase III clinical trials

• Based on services, the storage and distribution segment is anticipated to witness the fastest CAGR of over 6.7% from 2022 to 2030. The rise in globalbiologicspipeline and temperature-sensitive drugs are expected to increase the complexities related to logistics of clinical trial supplies

• The Biologics segment is expected to register the fastest CAGR owing to increasing research in the field of genetics and biotechnology, such as the development of nanoparticle-based drug delivery systems

• In terms of therapeutic use or clinical indication, the oncology segment dominated the market with a revenue share of over 38.0%in 2021. According to the United Press International, hospitals in the U.S. are disposing of millions of cancer drug vials due to improper dosage, which is indicative of the need for appropriate supply management

Clinical Trial Supplies Market Segmentation

Grand View Research has segmented the global clinical trial supplies market based on clinical phase, service, end use, therapeutic use, and region:

Clinical Trial Supplies clinical Phase Outlook (Revenue, USD Million, 2017 - 2030)

• Phase I

• Phase II

• Phase III

• Others

Clinical Trial Supplies Services Outlook (Revenue, USD Million, 2017 - 2030)

• Manufacturing

• Storage & Distribution

  • Cold Chain Distribution

  • Non-cold Chain

• Supply Chain Management

• Comparator Sourcing

Clinical Trial Supplies End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Pharmaceutical

• Biologics

• Medical Device

• Others

Clinical Trial Supplies Therapeutic Use Outlook (Revenue, USD Million; 2017 - 2030)

• Oncology

• CNS

• Cardiovascular

• Infectious Disease

• Metabolic Disorders

• Dermatology

• Ophthalmology

• Respiratory Diseases

• Others

Clinical Trial Supplies Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

  • Netherlands

  • Belgium

  • Switzerland

  • Russia

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South; Korea

  • Malaysia

  • Indonesia

  • Singapore

  • Philippines

• Latin America

  • Mexico

  • Brazil

  • Argentina

  • Colombia

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players in the Clinical Trial Supplies Market

• Almac Group Ltd.

• Biocair International Ltd.

• Catalent Pharma Solutions

• KLIFO A/S

• MOVIANTO (WALDEN GROUP)

• PCI Pharma Services

• Sharp Packaging Services

• Thermo Fischer Scientific, Inc.

• Marken

• PAREXEL International Corporation

• Patheon, Inc.

• Piramal Pharma Solutions

• UDG Healthcare

• EUROFINS

• PRA Health Sciences

• Liveo Research

Other players present in the market

• Clinigen Group plc

• Merck Serono

• Chimerix